Compounds > 8-hydroxy-2-(di-n-propylamino)tetralin
Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Heart Disease, Ischemic

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Heart Disease, Ischemic in 1 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellido, I1
Delange, L1
Gomez-Luque, A1

Other Studies

1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and Heart Disease, Ischemic

ArticleYear
The platelet of the patients with ischemic cardiopathy and cardiac valve disease showed a reduction of 8OH-DPAT binding sites.
    Thrombosis research, 2008, Volume: 121, Issue:4

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adult; Aged; Binding Sites; Blood Platelets; Female; Heart V

2008